基于细胞的生物仿真牙细胞纳米疫苗用于重编程免疫微环境以促进瘤免疫疗法
Weizhong Wang1,2, Cheng Zou1, Xiao Liu2
1Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.
ACS nano
|December 3, 2024
概括
一种模仿树突细胞 (DC) 的新型纳米疫苗HybridDC克服了传统DC疫苗的局限性. 这种个性化的纳米疫苗增强了抗原呈现和抗瘤免疫力,显示了癌症治疗的前景.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 树突细胞 (DC) 中介免疫疗法提供癌症治疗潜力,但面临挑战.
- 传统的DC疫苗存在抗原传递不良,淋巴结传导有限以及输血风险等问题.
研究的目的:
- 开发一个个性化的DC模仿纳米疫苗 (HybridDC),以增强抗原呈现和抗瘤免疫力.
- 解决传统DC疫苗的局限性,包括抗原输送和免疫细胞贩运.
主要方法:
- 来自DCs的工程细胞膜被用于创建混合DC纳米疫苗.
- 关键组成部分,如CCR7,瘤相关的抗原/外体,以及辅助刺激分子,都在膜上.
主要成果:
- 混合DC显示改善了淋巴组织的向,并调节了瘤免疫微环境.
- 在质瘤模型中观察到显著的治疗和预防性抗瘤疗效.
- 混合DC增强了免疫检查点阻塞 (ICB) 疗法,并诱导了长期保护性记忆T细胞免疫力.
结论:
- 混合DC代表了个性化癌症疫苗的有希望的平台.
- 这种纳米疫苗策略可以改善当前的免疫疗法,特别是与ICB结合使用.
相关概念视频
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338


